Clinical Trials
Sep 14, 2026 · 1 min read · 3,957 views
Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial
M
Maya Chen
Editorial · Sep 14, 2026
Olema Oncology is again teaming up with Novartis, with the companies partnering on a new clinical trial collaboration and supply agreement for an investigational breast
← Previous
Chinese startup begins first trial of in vivo CRISPR therapy for blood disease
Next →
Exclusive: ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition
